Skip to main content

THC clinical trials at University of California Health

3 in progress, 2 open to eligible people

Showing trials for
  • Efficacy of Inhaled Cannabis for Acute Migraine Treatment

    open to eligible people ages 21-65

    This crossover study will evaluate 3 different treatments of vaporized cannabis (THC, THC/CBD mix, and CBD) and vaporized placebo cannabis for the acute treatment of migraine.

    at UCSD

  • THC Crossover Study

    open to eligible people ages 21 years and up

    This is a randomized, crossover study enrolling experienced dual cannabis-tobacco smokers (N=18) to describe the differences in THC and toxicant exposure, examining pharmacokinetic, subjective, and cardiovascular effects from smoking and vaping dry herb cannabis. This study will also examine the differences in toxicant exposure and cardiovascular disease risk between smoking cannabis and smoking tobacco cigarettes.

    at UCSF

  • Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment

    Sorry, not yet accepting patients

    This pilot crossover study will evaluate 3 different potencies of inhaled cannabis (2.5%, 5%, and 10%) and inhaled placebo cannabis for the acute treatment of migraine.

    at UCSD

Our lead scientists for THC research studies include .

Last updated: